{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:05:38Z","timestamp":1771884338045,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Elderly patients are frequently in need of antithrombotic therapy for reducing thrombotic events. The association between antithrombotic drugs and survival after traumatic brain injury (TBI) is, nevertheless, unclear.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This retrospective study included patients \u226565 years admitted to a Norwegian Level 1 trauma center with TBI identified on cerebral computed tomography (cerebral-CT) during 2014\u20132019. Preinjury use of antiplatelets and anticoagulants was compared to the prescription rate in the general Norwegian population. The primary outcome was 30-day mortality. Uni- and multivariate logistic regression analyses estimated the association between the use of antithrombotic drugs and mortality.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The study includes 832 consecutive TBI patients \u226565 years. The median age was 76 years, 58% were males, 51% had moderate or severe TBI, and 39% had multiple traumas. Preinjury use of antithrombotics was registered in 471\/832 (55.6%) patients; antiplatelet therapy alone in 268, anticoagulant therapy alone in 172, and combined antiplatelet and anticoagulant therapy in 31. Antiplatelet use did not differ between the study cohort and the general Norwegian population \u226565 years (31 vs. 31%, <jats:italic>p<\/jats:italic> = 0.87). Anticoagulant therapy was used more commonly in the study cohort than in the general Norwegian population (24 vs. 19%, <jats:italic>p<\/jats:italic> = 0.04). Combined use of antiplatelet and anticoagulant therapy was significantly associated with 30-day mortality, while preinjury antiplatelet or anticoagulation treatment alone was not. No difference in 30-day mortality between patients using VKA, DOACs, or LMWH was encountered.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> In this cohort, neither antiplatelet nor anticoagulant therapy alone was associated with increased 30-day mortality. Anticoagulant use was more prevalent among TBI patients than the general population, suggesting that anticoagulation might contribute to the initiation of intracranial bleeding after blunt head trauma. Combined antiplatelet and anticoagulant therapy posed increased risk of 30-day mortality.<\/jats:p>","DOI":"10.3389\/fneur.2021.650695","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T06:44:01Z","timestamp":1620888241000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Impact of Preinjury Antithrombotic Therapy on 30\u2013Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)"],"prefix":"10.3389","volume":"12","author":[{"given":"P\u00e5l","family":"R\u00f8nning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirik","family":"Helseth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Skaansar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathrine","family":"Tverdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Andelic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Melberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils Oddvar","family":"Skaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads","family":"Aarhus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrun","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragnhild","family":"Helseth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"B1","volume-title":"The National Prescription Database","year":"2019"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1182\/blood.2019001881","article-title":"Acute treatment of venous thromboembolism","volume":"135","author":"Becattini","year":"2020","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0202575","DOI":"10.1371\/journal.pone.0202575","article-title":"Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: nationwide pharmacoepidemiological study","volume":"13","author":"Gulati","year":"2018","journal-title":"PLoS ONE"},{"key":"B9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1055\/s-0033-1357506","article-title":"Intracerebral bleeding in patients on antithrombotic agents","volume":"39","author":"Veltkamp","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1001\/jamaneurol.2018.2215","article-title":"Association of intracranial hemorrhage risk with non-vitamin K antagonist oral anticoagulant use vs aspirin use: a systematic review and meta-analysis","volume":"75","author":"Huang","year":"2018","journal-title":"JAMA Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jama.2017.0639","article-title":"Association of antithrombotic drug use with subdural hematoma risk","volume":"317","author":"Gaist","year":"2017","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2019.4.JNS19252","article-title":"Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes","volume":"5","author":"Scotti","year":"2019","journal-title":"J Neurosurg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1161\/STROKEAHA.120.030930","article-title":"Prognosis of intracerebral hemorrhage related to antithrombotic use: an observational study from the Swedish stroke register (Riksstroke)","volume":"52","author":"Apostolaki-Hansson","year":"2021","journal-title":"Stroke"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/02688697.2012.705361","article-title":"A meta-analysis to determine the effect of preinjury antiplatelet agents on mortality in patients with blunt head trauma","volume":"27","author":"Batchelor","year":"2013","journal-title":"Br J Neurosurg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/j.wneu.2018.02.167","article-title":"Patients with moderate and severe traumatic brain injury: impact of preinjury platelet inhibitor or warfarin treatment","volume":"114","author":"Tollefsen","year":"2018","journal-title":"World Neurosurg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12873-016-0094-1","article-title":"Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective cohort analysis from a level 1 trauma centre","volume":"16","author":"Narum","year":"2016","journal-title":"BMC Emerg Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3109\/02688697.2011.650736","article-title":"A meta-analysis to determine the effect of anticoagulation on mortality in patients with blunt head trauma","volume":"26","author":"Batchelor","year":"2012","journal-title":"Br J Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/TA.0000000000001995","article-title":"The novel oral anticoagulants (NOACs) have worse outcomes compared with warfarin in patients with intracranial hemorrhage after TBI","volume":"85","author":"Zeeshan","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1089\/neu.2019.6911","article-title":"Impact of antithrombotic agents on radiological lesion progression in acute traumatic brain injury: a CENTER-TBI propensity-matched cohort analysis","volume":"37","author":"Mathieu","year":"2020","journal-title":"J Neurotrauma"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e109473","DOI":"10.1371\/journal.pone.0109473","article-title":"Traumatic intracranial hemorrhage correlates with preinjury brain atrophy, but not with antithrombotic agent use: a retrospective study","volume":"9","author":"Dunham","year":"2014","journal-title":"PLoS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40621-020-00269-8","article-title":"Characteristics of traumatic brain injury patients with abnormal neuroimaging in Southeast Norway","volume":"7","author":"Tverdal","year":"2020","journal-title":"Inj Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/02699059509008203","article-title":"The head injury severity scale (HISS): a practical classification of closed-head injury","volume":"9","author":"Stein","year":"1995","journal-title":"Brain Inj"},{"key":"B23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1227\/00006123-199009000-00014","article-title":"Mild head injury classification","volume":"27","author":"Williams","year":"1990","journal-title":"Neurosurgery"},{"key":"B24","doi-asserted-by":"publisher","first-page":"415740","DOI":"10.1155\/2012\/415740","article-title":"Outcome from complicated versus uncomplicated mild traumatic brain injury","volume":"2012","author":"Iverson","year":"2012","journal-title":"Rehabil Res Pract"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1227\/01.NEU.0000186013.63046.6B","article-title":"Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors","volume":"57","author":"Maas","year":"2005","journal-title":"Neurosurgery"},{"key":"B26","unstructured":"32761068Guidelines for the Management of Severe TBI. 4th ed2016"},{"key":"B27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.annemergmed.2019.10.004","article-title":"Prevalence of intracranial injury in adult patients with blunt head trauma with and without anticoagulant or antiplatelet use","volume":"75","author":"Probst","year":"2020","journal-title":"Ann Emerg Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jemermed.2019.09.007","article-title":"Direct oral anticoagulant treatment and mild traumatic brain injury: risk of early and delayed bleeding and the severity of injuries compared with vitamin K antagonists","volume":"57","author":"Turcato","year":"2019","journal-title":"J Emerg Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2340\/16501977-1198","article-title":"Severe traumatic brain injury in Norway: impact of age on outcome","volume":"45","author":"Roe","year":"2013","journal-title":"J. Rehabil. Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S1474-4422(19)30232-7","article-title":"Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study","volume":"18","author":"Steyerberg","year":"2019","journal-title":"Lancet Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1741-7015-11-50","article-title":"Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update","volume":"11","author":"Unden","year":"2013","journal-title":"BMC Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/jamaneurol.2019.0932","article-title":"Risk for major hemorrhages in patients receiving clopidogrel and aspirin compared with aspirin alone after transient ischemic attack or minor ischemic stroke: a secondary analysis of the POINT randomized clinical trial","volume":"76","author":"Tillman","year":"2019","journal-title":"JAMA Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/eurheartj\/ehz726","article-title":"The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"40","author":"Konstantinides","year":"2019","journal-title":"Eur Heart J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/TA.0000000000001245","article-title":"Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: a TQIP study","volume":"81","author":"Feeney","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jamaneurol.2019.2099","article-title":"Clinical effectiveness of direct oral anticoagulants vs warfarin in older patients with atrial fibrillation and ischemic stroke: findings from the patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study","volume":"76","author":"Xian","year":"2019","journal-title":"JAMA Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jama.2017.21917","article-title":"Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality","volume":"319","author":"Inohara","year":"2018","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e003725","DOI":"10.1161\/JAHA.116.003725","article-title":"Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B41","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fneur.2020.00760","article-title":"Reversal treatment in oral anticoagulant-related intracerebral hemorrhage-an observational study based on the swedish stroke register","volume":"11","author":"Apostolaki-Hansson","year":"2020","journal-title":"Front Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/neuros\/nyx072","article-title":"Proposal for the rapid reversal of coagulopathy in patients with nonoperative head injuries on anticoagulants and\/or antiplatelet agents: a case study and literature review","volume":"81","author":"Watson","year":"2017","journal-title":"Neurosurgery"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ajem.2014.11.009","article-title":"Tranexamic acid in brain injury: devil in the detail","volume":"33","author":"Zehtabchi","year":"2015","journal-title":"Am J Emerg Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ajem.2014.09.023","article-title":"Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis","volume":"32","author":"Zehtabchi","year":"2014","journal-title":"Am J Emerg Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ajh.25475","article-title":"Reversal of direct oral anticoagulants: guidance from the Anticoagulation Forum","volume":"94","author":"Cuker","year":"2019","journal-title":"Am J Hematol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamainternmed.2018.7816","article-title":"Association of adding aspirin to warfarin therapy without an apparent indication with bleeding and other adverse events","volume":"179","author":"Schaefer","year":"2019","journal-title":"JAMA Intern Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ehjcvp\/pvz086","article-title":"Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study","volume":"6","author":"Rutherford","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.650695\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T06:44:05Z","timestamp":1620888245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.650695\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":48,"alternative-id":["10.3389\/fneur.2021.650695"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.650695","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"article-number":"650695"}}